Indication
Maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
Loading your page…
Loading your page…
Schizophrenia
Marketing Authorisation Holder: Otsuka Pharmaceutical Netherlands B.V.
EMA Authorisation: 14/11/2013
INN: aripiprazole
AI Drug & Interaction Analysis
Free account required
Ask Osler about Abilify Maintena: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.